Patients with ARHGAP26/6 fusion have distinct clinical characteristics, and ARHGAP26/6 fusion is enriched in patients with SRCC subtype, as well as younger age, higher female/male ratio, advanced tumor stage, which is in parallel with that for SRCC patients, thus can partially account for their clinical relevance. Here, ARHGAP26 is linked to neoplasm.